Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-25

Clinical Trial Update: Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome [Phase 3]

View source ↗

Summary

Phase 3 trial update for OPA-15406 ointment in adults with atopic dermatitis completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OPA-15406 ointment (OPA-15406)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2021-01-25